Shares of Catalyst Pharmaceuticals rose 2.69% to $3.63 at 16:06 EST on Thursday, after three consecutive sessions in a row of losses. The Nasdaq Stock Market is rising 0.57% to $12,419.90, following yesterday’s downward trend, on what at the moment seems, a somewhat positive trend trading session today.

Catalyst Pharmaceuticals’s last close was $3.54, 45.45% below its 52-week high of $5.28.

Catalyst Pharmaceuticals’s Sales

Catalyst Pharmaceuticals’s sales growth is 11.6% for the current quarter and 4.6% for the next. The company’s growth estimates for the present quarter is 25% and a drop 10% for the next.

Catalyst Pharmaceuticals’s Revenue

Year-on-year quarterly revenue growth declined by 5.1%, now sitting on 118.18M for the twelve trailing months.

Catalyst Pharmaceuticals’s Stock Top and Bottom Yearly Value

Catalyst Pharmaceuticals’s stock is valued at $3.63 at 16:06 EST, way under its 52-week high of $5.28 and way higher than its 52-week low of $2.55.

Catalyst Pharmaceuticals’s Moving Average

Catalyst Pharmaceuticals’s value is way above its 50-day moving average of $3.29 and under its 200-day moving average of $3.84.

LEAVE A REPLY

Please enter your comment!
Please enter your name here